Market Overview

UPDATE: Citigroup Downgrades Centene to Neutral on Limited Upside Potential

Share:
Related CNC
Top 4 Mid-Cap Stocks In The Health Care Plans Industry With The Highest EPS Growth Forecast For Next Year
Obamacare Could Be Setting Up A Bumper Year For Insurers

Citigroup downgraded Centene (NYSE: CNC) from Buy to Neutral and maintained its $45 price target.

Citigroup noted, "After a 6% move on Tuesday, and with the stock up 75% from its June low, we're taking a step back on Centene. Even with $15 billion in revenue (that's a 50% increase relative to projected 2013 revenue of $10 billion), and a 1.5% net margin, Centene would earn around $4/share, which at a 12x multiple would value the company at $48, only modestly higher than the current price."

Centene closed at $44.99 on Tuesday.

Latest Ratings for CNC

DateFirmActionFromTo
Feb 2015BarclaysMaintainsOverweight
Feb 2015Deutsche BankMaintainsHold
Jan 2015BarclaysMaintainsOverweight

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CNC)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→